GLUT1 expression, tumor proliferation, and iodine/FDG-uptake in thyroid cancer with emphasis on poorly-differentiated thyroid carcinoma

被引:0
|
作者
Nagarajah, J. [1 ]
Grabellus, F. [2 ]
Schmid, K. [2 ]
Bockisch, A. [1 ]
Sheu, S. [2 ]
机构
[1] Univ Hosp Essen, Clin Nucl Med, Essen, Germany
[2] Univ Hosp Essen, Inst Pathol & Neuropathol, Essen, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S111 / S112
页数:2
相关论文
共 46 条
  • [1] Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma
    Grabellus, Florian
    Nagarajah, James
    Bockisch, Andreas
    Schmid, Kurt Werner
    Sheu, Sien-Yi
    [J]. CLINICAL NUCLEAR MEDICINE, 2012, 37 (02) : 121 - 127
  • [2] Comparison of FDG uptake with GLUT1 and NIS expression in patients with untreated papillary thyroid carcinoma
    Choi, J. Y.
    Oh, Y. L.
    Jeong, H. S.
    Son, Y. I.
    Baek, C. H.
    Choi, Y.
    Choe, Y. S.
    Lee, K. H.
    Kim, B. T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S121 - S121
  • [3] Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid
    Matsumoto, Hirofumi
    Sakamoto, Atsuhiko
    Fujiwara, Masachika
    Yano, Yukiko
    Shishido-Hara, Yukiko
    Fujioka, Yasunori
    Kamma, Hiroshi
    [J]. ONCOLOGY REPORTS, 2008, 19 (06) : 1405 - 1411
  • [4] False positive FDG-uptake in neck and mediastinum in recurrent differentiated thyroid cancer (DTC)
    Biermann, Martin
    Reitan, Bernt
    Johnsen, Boel
    Haugland, Hans Kristian
    Akslen, Lars
    Varhaug, Jan
    Brauckhoff, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [5] Expression of GLUT1 in Neoplastic Cells of Papillary Thyroid Cancer
    Montazer, Fatemeh
    Alizadeh-Navaei, Reza
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (04): : 243 - 247
  • [6] PRECLINICAL EVIDENCES ON THE ACTIVITY OF EGFR1 INHIBITORS IN POORLY-DIFFERENTIATED THYROID CARCINOMA CELLS
    Maddalena, Francesca
    Fabiano, Annarita
    Piscazzi, Annamaria
    Farese, Anna
    Costantino, Eleonora
    Cignarelli, Mauro
    Landriscina, Matteo
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [7] Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
    Lukovic, Jelena
    Petrovic, Irina
    Liu, Zijin
    Armstrong, Susan M.
    Brierley, James D.
    Tsang, Richard
    Pasternak, Jesse D.
    Gomez-Hernandez, Karen
    Liu, Amy
    Asa, Sylvia L.
    Mete, Ozgur
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [8] GLUT1 EXPRESSION IN HEPATOCELLULAR CARCINOMA: CORRELATION WITH 18F-FDG UPTAKE
    Brito, A. F.
    Abrantes, A. M.
    Pinto-Costa, C.
    Mamede, C.
    Matos, C.
    Rodrigues, M. C.
    Goncalves, A. C.
    Rodrigues, A.
    Sarmento-Ribeiro, A. B.
    Castro-Sousa, F.
    Botelho, M. F.
    Tralhao, J. G.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S84 - S84
  • [9] Incremental value of a complementary neck acquisition during 18F-FDG-PET/CT in patients with differentiated or poorly-differentiated thyroid cancer
    Ciappuccini, R.
    Aide, N.
    Rame, J.
    Michels, J.
    Heutte, N.
    Quak, E.
    Bardet, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S464 - S464
  • [10] Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells
    Fortunati, N
    Catalano, MG
    Arena, K
    Brignardello, E
    Piovesan, A
    Boccuzzi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02): : 1006 - 1009